Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative …
F Yang, Wendusubilige, J Kong, Y Zong, M Wang… - EPMA Journal, 2023 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a poor
prognosis that currently lacks effective treatment methods. Preventing the acute …
prognosis that currently lacks effective treatment methods. Preventing the acute …
Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative …
F Yang, J Kong, Y Zong, M Wang, C Jing, Z Ma… - The EPMA …, 2023 - europepmc.org
Background Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a poor
prognosis that currently lacks effective treatment methods. Preventing the acute …
prognosis that currently lacks effective treatment methods. Preventing the acute …
Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative …
F Yang, J Kong, Y Zong, M Wang, C Jing… - The EPMA …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a poor
prognosis that currently lacks effective treatment methods. Preventing the acute …
prognosis that currently lacks effective treatment methods. Preventing the acute …
[PDF][PDF] Identifying oxidative stress‑related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using …
Z Ma, W Li, R Cao, S Jing, J Gao, W Li, J Wang - researchgate.net
Background Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a poor
prognosis that currently lacks effective treatment methods. Preventing the acute …
prognosis that currently lacks effective treatment methods. Preventing the acute …